Cargando…

Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy

BACKGROUND: Clustered Regularly Interspaced Short Palindromic Repeats-associated (CRISPR-Cas) technology may allow for efficient and highly targeted gene editing in single-cell embryos. This possibility brings human germline editing into the focus of ethical and legal debates again. MAIN BODY: Again...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schleidgen, Sebastian, Dederer, Hans-Georg, Sgodda, Susan, Cravcisin, Stefan, Lüneburg, Luca, Cantz, Tobias, Heinemann, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Debate
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488432/ https://www.ncbi.nlm.nih.gov/pubmed/32912206 http://dx.doi.org/10.1186/s12910-020-00487-1

Ejemplares similares

Synthetic Notch-Receptor-Mediated Transmission of a Transient Signal into Permanent Information via CRISPR/Cas9-Based Genome Editing
por: Sgodda, Malte, et al.
Publicado: (2020)

Global constitutionalism, applied to global health governance: uncovering legitimacy deficits and suggesting remedies
por: Ooms, Gorik, et al.
Publicado: (2016)

Is selecting better than modifying? An investigation of arguments against germline gene editing as compared to preimplantation genetic diagnosis
por: v. Hammerstein, Alix Lenia, et al.
Publicado: (2019)

Trust in Science: CRISPR–Cas9 and the Ban on Human Germline Editing
por: Guttinger, Stephan
Publicado: (2017)

CRISPR-Cas systems: ushering in the new genome editing era
por: Perez Rojo, Fernando, et al.
Publicado: (2018)

Is uncertainty in complex disease epidemiology resolvable?
por: Maziak, Wasim
Publicado: (2015)

Framing the ethical and legal issues of human artificial gametes in research, therapy, and assisted reproduction: A German perspective
por: Advena‐Regnery, Barbara, et al.
Publicado: (2018)

Known unknowns: building an ethics of uncertainty into genomic medicine
por: Newson, Ainsley J., et al.
Publicado: (2016)

Prevention, control, and elimination of neglected diseases in the Americas: Pathways to integrated, inter-programmatic, inter-sectoral action for health and development
por: Holveck, John C, et al.
Publicado: (2007)

Generation of germline ablated male pigs by CRISPR/Cas9 editing of the NANOS2 gene
por: Park, Ki-Eun, et al.
Publicado: (2017)

Targeted delivery of CRISPR-Cas9 ribonucleoprotein into arthropod ovaries for heritable germline gene editing
por: Chaverra-Rodriguez, Duverney, et al.
Publicado: (2018)

Germline stem cells in the postnatal mammalian ovary: A phenomenon of prosimian primates and mice?
por: Telfer, Evelyn E
Publicado: (2004)

Human genome editing: how to prevent rogue actors
por: Townsend, Beverley A.
Publicado: (2020)

Human rights in the biotechnology era 1
por: Benatar, Solomon R
Publicado: (2002)

Embracing uncertainty, managing complexity: applying complexity thinking principles to transformation efforts in healthcare systems
por: Khan, Sobia, et al.
Publicado: (2018)

Pertussis re-emergence in the post-vaccination era
por: Chiappini, Elena, et al.
Publicado: (2013)

Defining “mutation” and “polymorphism” in the era of personal genomics
por: Karki, Roshan, et al.
Publicado: (2015)

CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

CRISPR/Cas based gene editing: marking a new era in medical science
por: Prasad, Kirti, et al.
Publicado: (2021)

Genome editing of pseudorabies virus in the CRISPR/Cas9 era: a mini-review
por: Wang, Hai-Ming, et al.
Publicado: (2023)

Human dignity in the Nazi era: implications for contemporary bioethics
por: O'Mathúna, Dónal P
Publicado: (2006)

Higher doses of naloxone are needed in the synthetic opiod era
por: Moss, Ronald B., et al.
Publicado: (2019)

Endometrial Receptivity Analysis (ERA) test: an unproven technology
por: Ben Rafael, Zion
Publicado: (2021)

Enhancing the scoping study methodology: a large, inter-professional team’s experience with Arksey and O’Malley’s framework
por: Daudt, Helena ML, et al.
Publicado: (2013)

Human difference in the genomic era: Facilitating a socially responsible dialogue
por: Knerr, Sarah, et al.
Publicado: (2010)

India’s NCD strategy in the SDG era: are there early signs of a paradigm shift?
por: Mondal, Shinjini, et al.
Publicado: (2018)

Privacy and artificial intelligence: challenges for protecting health information in a new era
por: Murdoch, Blake
Publicado: (2021)

The role of disruptive technologies and approaches in ERAS®: erupting change through disruptive means
por: Baimas-George, Maria, et al.
Publicado: (2022)

Strengthening the WHO in the pandemic era by removing a persistent structural defect in financing
por: M’ikanatha, Nkuchia M., et al.
Publicado: (2021)

Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

Prevention of pneumococcal diseases in the post-seven valent vaccine era: A European perspective
por: Weil-Olivier, Catherine, et al.
Publicado: (2012)

Debate: Recognising and responding to the mental health needs of young people in the era of COVID‐19
por: Danese, Andrea, et al.
Publicado: (2020)

“The post-COVID era”: challenges in the treatment of substance use disorder (SUD) after the pandemic
por: López-Pelayo, Hugo, et al.
Publicado: (2020)

We need to think about data governance for dementia research in a digital era
por: Milne, Richard, et al.
Publicado: (2020)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

Pathogen detection in the CRISPR–Cas era
por: Sashital, Dipali G.
Publicado: (2018)

Exploratory trials, confirmatory observations: A new reasoning model in the era of patient-centered medicine
por: Sacristán, José A
Publicado: (2011)

Gastrointestinal cancer surgery and enhanced recovery after surgery (ERAS) during COVID-19 outbreak
por: Sica, G. S., et al.
Publicado: (2020)

Germline CRISPR/Cas9-Mediated Gene Editing Prevents Vision Loss in a Novel Mouse Model of Aniridia
por: Mirjalili Mohanna, Seyedeh Zeinab, et al.
Publicado: (2020)

Commentary: RNA editing with CRISPR-Cas13
por: Matsoukas, Ianis G.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eqp5r25f45g0e4ubtvfktqv94a